Preventing cerebral palsy in premature babies: the PReCePT programme
The PReCePT programme to increase the use of magnesium sulfate, a £1 injection that helps prevent cerebral palsy in premature babies, is effective and cost-effective according to our evaluation published in the Archives of Disease in Childhood.
Our applied health research and implementation focus on projects on mental health, public health and prevention, healthier childhoods and integrated and optimal care.
We are committed to a collaborative approach to patient and public involvement in research and the delivery of health care and services, through our partners People in Health West of England.
Our training and capacity building work promotes the development of skills in understanding, using and producing evidence for the health and social care, public health and commissioning workforce, as well as the voluntary sector.
